Houttuynia cordata

Houttuynia cordata contains the ketone 2-undecanone, the monoterpene β-myrcene, capric acid (n-decanoic acid), and flavonoids quercetin and kaempferol that collectively activate the Nrf2-HO-1/NQO-1 cytoprotective pathway, suppress NF-κB/MAPK inflammatory signaling, and engage antiviral targets including the SARS-CoV-2 3CL protease and RNA-dependent RNA polymerase. In preclinical murine models, oral administration of 25–50 g/kg HCT extract or 100–200 mg/kg 2-undecanone significantly suppressed benzo(a)pyrene-induced lung tumorigenesis, reduced pulmonary ROS, lowered DNA damage marker p-H2A.X, and decreased pro-inflammatory IL-1β secretion (p < 0.001 versus model controls) without observable systemic toxicity.

Origin & History

Houttuynia cordata Thunb. (family Saururaceae) is native to moist, shaded environments across Southeast and East Asia, including Vietnam, China, Japan, Korea, and the eastern Himalayan foothills, where it thrives in humid soils near water and forest margins at low to mid elevations. The plant is a perennial rhizomatous herb cultivated both wild-harvested and as a garden crop throughout its range, with the leaves, aerial parts, and underground rhizomes all used medicinally and culinarily. In Vietnam it is commonly eaten fresh as an herb in salads and soups and referred to colloquially as 'fish mint' or 'giấp cá,' while Chinese and Japanese traditions primarily exploit dried extracts and essential oils from the whole plant.

Historical & Cultural Context

Houttuynia cordata has been documented in Chinese traditional medicine (TCM) texts for over a millennium under the name 'Yú Xīng Cǎo' (fish-smelling herb), where it was applied for lung heat, pulmonary abscess, urinary infections, and toxic swellings, with formal inclusion in the Chinese Pharmacopoeia reflecting its enduring clinical relevance. In Vietnam, the herb occupies a dual culinary-medicinal role as 'giấp cá,' routinely consumed raw in pork dishes and herbal platters while simultaneously prescribed by traditional healers for fever, infections, and detoxification, making it one of the most culturally embedded medicinal herbs in Indochina. Japanese Kampo medicine employs it as 'Dokudami' ('poison-blocking plant') in topical preparations for skin infections and as a tea for hypertension and constipation, while Korean folk medicine similarly uses decoctions for detoxification and anti-inflammatory purposes. The plant gained international scientific attention during the 2003 SARS-CoV-1 outbreak when Chinese researchers reported antiviral activity of HCT extracts against the coronavirus, catalyzing a wave of molecular investigations that continued through the COVID-19 pandemic.

Health Benefits

- **Antiviral Activity**: Quercetin and kaempferol from H. cordata bind to the SARS-CoV-2 3CL protease (3CLpro) and RNA-dependent RNA polymerase (RdRp) active sites in silico, while network pharmacology mapping identifies 18 enriched pathways including NF-κB and MAPK signaling (adjusted P = 2.12E-11), suggesting broad-spectrum antiviral potential confirmed historically against SARS-CoV-1.
- **Anti-Inflammatory Effects**: Whole-plant extracts and isolated flavonoids dose-dependently inhibit LPS-stimulated macrophage production of pro-inflammatory cytokines via NF-κB p65 (RELA) and MAPK1 suppression; anti-inflammatory IC50 has been measured at 1.176 µg/mL in cell-based assays.
- **Antioxidant Protection**: H. cordata extracts scavenge hydroxyl and superoxide radicals at 6–6.25 mg/mL, achieve a DPPH IC50 of 13.25 mg/mL and a FRAP value of 17.44 mg TEAC/g, and outperform vitamin E in a bleomycin-induced murine pulmonary fibrosis model by reducing malondialdehyde and superoxide dismutase elevation.
- **Lung Tumor Suppression**: 2-Undecanone (6.25–200 µM in vitro; 100–200 mg/kg in vivo) and HCT extracts activate the Nrf2-HO-1/NQO-1 antioxidant response element pathway, reversing benzo(a)pyrene-induced G0/G1 cell cycle arrest from 70.21% back toward control levels and reducing p-H2A.X DNA damage markers (p < 0.001).
- **Pulmonary Fibrosis Mitigation**: In a bleomycin mouse model, HCT extract reduced tissue hydroxyproline deposition, suppressed TGF-β1/Smad fibrotic signaling, lowered malondialdehyde, and boosted interferon-gamma (IFN-γ), collectively attenuating pathological lung remodeling.
- **Tyrosinase Inhibition and Skin-Relevant Antioxidation**: Essential oil fractions demonstrate tyrosinase inhibitory activity with an IC50 of 48 mg/mL, suggesting potential utility in hyperpigmentation applications, mediated partly by phenolic flavonoids that chelate the copper active site of the enzyme.
- **Immunomodulation**: Quercetin and kaempferol modulate IL-6, downregulate aberrant T-cell proliferation, and regulate protein kinase C (PKC) activity across mapped COVID-19-relevant signaling networks, indicating broader immunoregulatory capacity beyond any single pathogen target.

How It Works

The principal chemopreventive mechanism of Houttuynia cordata centers on 2-undecanone and whole-extract bioactives activating the Nrf2 transcription factor, which translocates to the nucleus and upregulates cytoprotective enzymes heme oxygenase-1 (HO-1) and NAD(P)H quinone oxidoreductase-1 (NQO-1), thereby quenching reactive oxygen species and mitigating oxidative DNA damage quantified as reduced phospho-H2A.X (γH2A.X) foci. Simultaneously, these compounds suppress canonical NF-κB pathway activation—blocking IκB phosphorylation and p65 nuclear translocation—and inhibit MAPK cascades (ERK, JNK, p38), leading to reduced transcription of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α in macrophages and epithelial cells. The flavonoids quercetin and kaempferol engage antiviral targets by directly docking into the substrate-binding cleft of SARS-CoV-2 3CL protease and occluding the catalytic dyad (His41-Cys145), and additionally intercalate with the RdRp palm domain to impede viral RNA replication, as characterized by network pharmacology and molecular docking analyses. Anti-fibrotic effects are achieved through TGF-β1/Smad pathway suppression—reducing Smad2/3 phosphorylation, decreasing collagen (hydroxyproline) deposition, and restoring IFN-γ-mediated immune balance—while capric acid (n-decanoic acid) and β-myrcene contribute membrane-disrupting antimicrobial and analgesic/anti-nociceptive activities via TRPV1 and prostaglandin modulation.

Scientific Research

The evidence base for Houttuynia cordata consists predominantly of in vitro cell culture studies and small-animal preclinical experiments, with no published human randomized controlled trials identified in the current literature. Murine studies have demonstrated statistically significant suppression of benzo(a)pyrene-induced lung tumorigenesis at HCT doses of 25–50 g/kg and 2-undecanone doses of 100–200 mg/kg, with p-values of p < 0.001 for ROS reduction, DNA damage, and IL-1β secretion endpoints, though group sizes are small (n = 3–6 per group) and the allometric doses are not directly translatable to human equivalents. Network pharmacology and molecular docking analyses have systematically mapped 18 KEGG pathways relevant to COVID-19 pathology (adjusted P = 2.12E-11), and in vitro antioxidant characterization (DPPH, FRAP, tyrosinase, radical scavenging) has been reproducibly reported across multiple laboratories, lending mechanistic credibility but not clinical proof-of-efficacy. Overall, the evidence tier remains preliminary; robust clinical translation requires dose-escalation pharmacokinetic studies, bioavailability data in humans, and adequately powered RCTs.

Clinical Summary

No human clinical trials with defined sample sizes, randomization, or quantified effect sizes have been published for Houttuynia cordata as a dietary supplement or pharmaceutical intervention in peer-reviewed literature available through the current search. Preclinical in vivo data from murine benzo(a)pyrene lung tumorigenesis models show statistically significant reductions in tumor markers (p < 0.001), DNA damage indices, and pro-inflammatory cytokines at doses of 25–50 g/kg HCT extract and 100–200 mg/kg 2-undecanone, without observed systemic toxicity, providing a safety and efficacy signal warranting human study. A bleomycin pulmonary fibrosis mouse model separately demonstrated superiority over vitamin E in reducing oxidative lung injury markers, further supporting mechanistic plausibility. Confidence in clinical applicability remains low due to the complete absence of human pharmacokinetic, bioavailability, or trial data; the evidence base, while biologically coherent, does not yet support specific therapeutic claims in human populations.

Nutritional Profile

Fresh Houttuynia cordata leaves provide modest macronutrient content typical of leafy vegetables (predominantly water ~85–90%, with low caloric density), and supply micronutrients including vitamin C, potassium, and calcium at concentrations comparable to common culinary herbs though precise values vary by growing region and have not been comprehensively tabulated in major food composition databases. Phytochemically, the plant is rich in flavonoids: quercetin and its glycosides quercitrin (quercetin-3-rhamnoside) and hyperoside (quercetin-3-galactoside), as well as kaempferol, collectively representing the major polyphenol fraction; total flavonoid content in dried extracts can reach several percent by weight depending on extraction solvent. The essential oil fraction (0.05–0.1% of fresh weight by steam distillation) is dominated by n-decanoic acid (capric acid, ~46%), 2-undecanone (~20–24%), and β-myrcene (~14–31% in leaves), with these volatiles responsible for the characteristic fish-like odor. Bioavailability of quercetin glycosides from whole herb is expected to be moderate (estimated 25–50% for aglycone after intestinal deglycosylation by β-glucosidases), though no specific pharmacokinetic data for Houttuynia-derived quercetin in humans have been published.

Preparation & Dosage

- **Traditional Aqueous Decoction (Tea)**: 9–15 g dried aerial herb per 500 mL water, simmered 15–20 minutes; consumed in 2–3 divided doses daily in Vietnamese and Chinese folk medicine for respiratory infections and inflammation.
- **Standardized Hydroalcoholic Extract (Capsule/Tablet)**: No pharmacopoeial human dose established; preclinical effective in vivo doses in mice (25–50 g/kg body weight) require allometric scaling before human application and have not yet been validated in clinical trials.
- **Essential Oil**: Extracted by hydrodistillation from leaves or underground parts; n-decanoic acid comprises ~46% and 2-undecanone ~20% of the oil; topical or inhalation uses reported traditionally, but no standardized human dosing exists.
- **Fresh Herb (Culinary/Functional Food)**: Commonly consumed raw in Vietnamese cuisine (giấp cá) as a salad herb alongside meat dishes; intake estimated at 10–50 g fresh herb per meal, providing flavonoids quercetin and kaempferol at food-relevant doses.
- **Standardization Note**: No internationally recognized standardization marker percentage is established; commercial extracts sometimes standardize to total flavonoid content (expressed as quercetin equivalents), but specific benchmarks vary by manufacturer.
- **Timing**: Traditional use is typically with meals; no circadian optimization data are available from human studies.

Synergy & Pairings

Quercetin from Houttuynia cordata pairs mechanistically with bromelain, which enhances quercetin intestinal absorption by deglycosylating quercetin conjugates and reducing mucosal barrier resistance, a combination documented to increase plasma quercetin bioavailability in human pharmacokinetic studies. The NF-κB inhibitory activity of HCT flavonoids may be synergistically amplified by co-administration with curcumin (from Curcuma longa), which independently blocks NF-κB at the IKK phosphorylation step and further suppresses MAPK signaling, creating dual-point pathway blockade that preclinical anti-inflammatory data suggest produces additive to synergistic cytokine suppression. For antiviral stacks, pairing HCT quercetin with zinc (which is required as a cofactor for quercetin's ionophore-mediated inhibition of RNA-dependent RNA polymerase) and vitamin C (which regenerates oxidized quercetin and extends its antioxidant half-life) constitutes a mechanistically coherent combination used in integrative respiratory infection protocols.

Safety & Interactions

In preclinical murine studies, oral administration of Houttuynia cordata extract at antitumor doses (25–50 g/kg) and 2-undecanone (100–200 mg/kg) produced no observable systemic toxicity, and in vitro viability of BEAS.2B bronchial epithelial cells was maintained at concentrations up to 200 mg/L HCT extract and 200 µM 2-undecanone over 48 hours, suggesting a favorable preliminary safety window. No formal human safety studies, maximum tolerated dose determinations, or genotoxicity assessments have been published, and the absence of clinical trial data means side effects, drug interactions, and contraindications in humans cannot be characterized with confidence. Theoretically, the quercetin content may interact with CYP3A4 and P-glycoprotein-mediated drug metabolism, potentially affecting bioavailability of co-administered pharmaceuticals including certain immunosuppressants (cyclosporine), anticoagulants (warfarin), and antiviral drugs; patients on these medications should consult a physician before use. Pregnancy and lactation safety has not been established; the herb's historical use as a detoxifying agent in Asian traditions does not constitute evidence of perinatal safety, and use during pregnancy or breastfeeding is not recommended without medical supervision.